Evidence map›Paper›PMID 42362534›Full record

ArticleSignal transduction and targeted therapy2026

Correction: Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir.

Yifan Zhang, Yanmin Wan, Cuiyuan Guo, Zhaoqin Zhu, Chao Qiu, Jiasheng Lu, Yanan Zhou, Jiaojiao Zheng, Fahui Dai, Xiaoyang Cheng and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Yifan Zhang *Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University; Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Yanmin Wan *Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University; Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China. yanmin_wan@fudan.edu.cn.ORCID http://orcid.org/0000-0001-5027-9423
Cuiyuan Guo *Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai, China.
Zhaoqin Zhu *Department of laboratory medicine, Shanghai Public Health Clinical Center, Shanghai, China.
Chao Qiu *Institutes of biomedical sciences & Shanghai Key Laboratory of Medical Epigenetics, Fudan University, Shanghai, China.ORCID http://orcid.org/0000-0001-9401-5219
Jiasheng LuSchool of Life Sciences, Fudan University, Shanghai, China.
Yanan ZhouInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Jiaojiao ZhengBiosafety Level 3 Laboratory, Shanghai Public Health Clinical Center, Shanghai, China.
Fahui DaiBiosafety Level 3 Laboratory, Shanghai Public Health Clinical Center, Shanghai, China.
Xiaoyang ChengDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University; Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Kunlu DengDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University; Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China.
Wanhai WangClinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Key Laboratory of Laboratory Medicine of Henan Province, Zhengzhou, China.
Youchun WangInstitute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China. wangyc@nifdc.org.cn.ORCID http://orcid.org/0000-0001-9769-5141
Wenhong ZhangDepartment of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University; Shanghai Sci-Tech Inno Center for Infection & Immunity, Shanghai, China. zhangwenhong@fudan.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42362534
PMCPMC13309539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.